In the highly regulated pharmaceutical industry, FDA inspections are a true test of a company's quality management. March 2025 proved to be a remarkable month for our company as we helped three companies successfully pass their FDA inspections, a testament to our professional expertise.

NCPC AINO and a well-known Hubei pharmaceutical company had already triumphed under our guidance. Adding to this success, Inner Mongolia Grint Pharmaceutical Co., Ltd. also passed its FDA on-site inspection from March 24th to 27th.

While some may attribute success to luck, GMP emphasizes that "Good luck = doing the right thing x doing it well." Our collaboration with companies like Grint exemplifies this principle, adhering to GMP regulations and assisting them in meeting international standards with professionalism and rigor.

These three successful inspections are a result of our dedication and pursuit of excellence. As we look ahead, we will continue to partner with more pharmaceutical companies, striving for compliance and creating a brilliant future together.